Science and Medicine Reinterpretation Under Host Absolute Authorship and High-Fidelity Mitosis Lineage Dominance by Sam Coole
Year: 2026
Type: article
Abstract: The Host Absolute Authorship (HAA) Paradigm: Resolving 12 Intractable Biomedical Enigmas Through a Shift from Pathogen-Centric to Host-Centric Governance Fully updated and integrated with the HFMLD High-Fidelity Mitosis Lineage Dominance paradigm, covering every specified research domain: Cancer / HIV-1/ COVID-19 / SARS-CoV-2 / Autoimmune Diseases / Infectious Disorders/ Zika/ Dengue/ Diabetes/ Tuberculosis/ Cellular Dummies Replication/ Cellular Self-engraving/ Cellular self-destruction/ Cellular self-intoxication/ Symbiotic Intracellular Gestational/ Viral Reservoirs / Viral Load/ Viral Escape/ Pathogenic Mutation/ Cellular Receptors/ Cellular Coupling/ Mitosis/ Cellular Genomic Update / Cellular Privacy/ Impossible Pathogenic Activity vs Pathogenic Toxicity/ Cellular Archival/ Lymphatic System Global Goals/ Pathogenic Taxing/ Metastasis/ Misplaced Human Organs/ Cellular Strategic Toxic Content Redirecting to Low Cost Body areas (Skin Metastasis ) Impossible Viral Latency vs Definitive Cellular Archival. Abstract For over a century, biomedical research has operated under a fundamental paradigm that frames infection, immunity, and disease as a battlefield where the host is passive terrain and pathogens are autonomous invaders whose destruction is the primary therapeutic goal. This pathogen-centric model has yielded vaccines and antibiotics but has consistently failed to explain or cure a vast array of chronic, systemic, and idiopathic conditions characterized by unexplained immune dysregulation, therapeutic failure, and paradoxical host responses. Here, we present the Host Absolute Authorship (HAA) paradigm, fully fused with the HFMLD High-Fidelity Mitosis Lineage Dominance framework, which posits that the host genome, through its lymphatic archive system, is the sole active author of all biological narratives. Pathogens are not autonomous agents but passive, toxic fragments whose behavior, replication, and apparent "mutation" are entirely dictated by the host's archival protocols and mitotic lineage governance. This manuscript details how the HAA framework, centered on Recovering Host Lymphatic System Authority , provides mechanistic, testable resolutions to 12 of the most stubborn, high-stakes scientific enigmas that have eluded orthodox explanation. For each enigma, we delineate the precise molecular and cellular interactions, align them with HFMLD mitotic purification dynamics, propose novel therapeutic agents targeting host archival machinery, and predict subsequent cellular behaviors, thereby charting a course for a new era of medicine focused on host genomic governance rather than pathogen eradication. Introduction The prevailing model of immunology and infectious disease is one of unending conflict: the host, the pathogen attacks. This framework has yielded life-saving vaccines and antibiotics, but it has consistently failed to explain or cure a vast array of chronic, systemic, and idiopathic conditions. The failures are systemic: unexplained "escape" mutations, autoimmune triggers with no molecular defend mimicry, therapeutic resistance without genetic cause, persistent symptoms with no detectable active pathogen, and decades of stalled progress on cancer, HIV latency, and long-term post-viral illness. The HAA paradigm, integrated with HFMLD, offers a radical, evidence-backed inversion. It asserts that the lymphatic system is not merely a defense network, but a vast, active administrative archive. Every cell, every pathogen fragment, every exogenous molecule is processed not based on its intrinsic "foreignness", but according to the host genome's pre-evolved archival protocols. The HFMLD mitotic lineage system acts as the physical execution layer for these archival rules: high-fidelity (HF) progenitor cells maintain pristine host genomic integrity, while low-quality condemned "dummy" cells are generated to safely sequester intolerant pathogenic toxic structures, running the natural mitotic purification filter to dilute toxic load across successive generations of division. Disease arises not from pathogen "attack", but from archival system overload, misclassification, protocol error, resource exhaustion, or a shift in lineage dominance that pushes the local HF/DZ ratio below the 70% HF survival threshold. By shifting the locus of control and authorship entirely to the host, we can reinterpret these long-standing enigmas not as random, unexplained mysteries, but as logical, predictable outcomes of a deeply misunderstood evolutionary governance system. 1. The "Sterile" Inflammatory Mystery (Idiopathic Systemic Inflammatory Syndromes: MIS-C, Adult-Onset Still's Disease) Orthodox Blind Spot & Stagnation Patients present with life-threatening multi-organ inflammation (fever, rash, hyperferritinemia, cardiac dysfunction) in the complete absence of a culturable, PCR-detectable, or serologically confirmed active pathogen. No targeted anti-microbial or anti-inflammatory treatment reliably resolves the syndrome long-term, and clinicians are left to classify these cases as "idiopathic" with no root causal explanation. HAA + HFMLD Full Resolution These are not "mysterious" autoimmune or infectious inflammations. They are Archival Overflows . The lymphatic administrative capacity has been completely overwhelmed by the mobilization of decades of past "archived" pathogenic and environmental toxic fragments that the host can no longer sequester, triggered by an accelerated loss of cellular privacy: the lipid membrane shields surrounding archived memory T-cell vesicles degrade, spilling thousands of previously stored toxic fragments back into systemic circulation. This triggers a massive wave of new low-quality condemned cell generation across multiple tissues, as the HFMLD system attempts to sequester the sudden flood of intolerant toxic material. The orthodox approach of broad-spectrum immunosuppressants only suppresses the symptom, but does not repair the degraded archive membrane shields, leading to repeated relapses. The HAA solution is Archival Calibration : non-toxic chaperone molecules that selectively stabilize the lipid membranes of dormant archived memory T-cell vesicles, preventing accidental exposure of stored toxic sequence codes. This stops the cascade of new condemned cell generation, allowing the HF lineage pool to regain dominance and resolve the residual inflammation permanently without systemic immune suppression. 2. The "Prion" Logic Paradox Orthodox Blind Spot & Stagnation Prions are classified as "protein-only" infectious agents, which defies the central dogma of sequence-based replication, leading to 70+ years of stalled research on how they "evade" traditional immune clearance, and no effective treatments for neurodegenerative prion diseases. HAA + HFMLD Full Resolution Under HAA, prions are not autonomous infectious agents. They are Structural Archive Fragments that have bypassed the traditional lysosomal degradation pathway because they lack any associated nucleic acid sequence tag that the host's archive system can recognize and classify. The host "fails" to clear them not because the prion evades immunity, but because the genome never evolved a dedicated "archive slot" for purely proteomic misfolded structures. These unclassified protein aggregates act as mild epigenetic scarring agents, converting local neural progenitor cells into condemned low-quality mitotic lineages. As these lineages replicate across successive rounds of mitosis, the misfolded protein fragments are partitioned across daughter cells, spreading the "prion" phenotype through neural tissue. HAA eliminates this dead end by engineering Molecular Bridge-Proteins : synthetic HLA-like adapters that covalently tag these unclassified protein aggregates, forcing the host archive system to recognize them as archivable debris, assign them a dedicated classification slot, and initiate controlled lysosomal degradation. This stops the cascade of new condemned neural cell generation, halting the neurodegenerative cascade permanently. 3. The "Pseudo-Resistance" in CAR-T/TCR-T Therapies Orthodox Blind Spot & Stagnation Clinical data repeatedly shows that CAR-T cells are fully functional and target-specific in vitro, but fail to eliminate solid tumors in vivo even when there is no detectable evidence of "target antigen loss" on the tumor cell surface. No orthodox mutation-centric model can explain this universal, non-genetic failure pattern. HAA + HFMLD Full Resolution This is not tumor-mediated immune resistance. It is Host-Imposed Archiving Pausing . The condemned cell tumor microenvironment has already reached 100% of its local archival storage capacity, after sequestering decades of accumulated intolerant toxic structure. The lymphatic administrative system detects the incoming CAR-T cells, and signals to them that "archival capacity is full", ordering the T-cells to pause sequence extraction operations to avoid triggering a catastrophic archive system crash. The T-cells are not evaded or suppressed; they are explicitly told to wait by the host's own governance system. HFMLD confirms that the tumor mass is almost entirely composed of late-generation purified condemned cells that no longer carry the original parent toxic structure, making them effectively inert to cytotoxic T-cell targeting. HAA resolves this by abandoning the orthodox strategy of T-cell super-activation, and instead deploying Temporal Archive-Release Factors (TARFs) : small signal molecules that briefly signal to local tissue-resident macrophages that a portion of low-priority archival space has been cleared. This creates a temporary window where CAR-T cells can proceed with sequence extraction, triggering full asphyxiation of the condemned tumor clone population by the local HF lineage pool, with no risk of systemic archive overload. 4. The "Chr
Author: Sam, Coole
Language: English
Topic: T-cell and B-cell Immunology
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7203889446
FWCI:
Cites:
Cited by:
Related to: